| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/17/2002 | WO2002004946A2 Methods for identifying combinations of drugs |
| 01/17/2002 | WO2002004945A1 Clinical method for the genetic screening of newborns using tandem mass spectrometry |
| 01/17/2002 | WO2002004944A1 Means of assaying immune function |
| 01/17/2002 | WO2002004943A2 Electrophysiology configuration suitable for high throughput screening of compounds for drug discovery |
| 01/17/2002 | WO2002004942A1 Saliva testing and confirmation device |
| 01/17/2002 | WO2002004941A2 On-line deposition monitor |
| 01/17/2002 | WO2002004931A1 Luminous reaction measuring device |
| 01/17/2002 | WO2002004923A2 Repeated impact apparatus and method for characterizing granule strength |
| 01/17/2002 | WO2002004921A2 Apparatus and method for biological sample preparation and analysis |
| 01/17/2002 | WO2002004919A2 Method and apparatus for the assay of precious metals |
| 01/17/2002 | WO2002004918A2 Nanoporous membrane immunosensor |
| 01/17/2002 | WO2002004915A2 Device and method for molecular detection |
| 01/17/2002 | WO2002004914A2 Optical food oil quality sensor |
| 01/17/2002 | WO2002004685A1 Method for determining three-dimensional protein structure from primary protein sequence |
| 01/17/2002 | WO2002004684A1 Role of pph1 gene in pulmonary hypertension |
| 01/17/2002 | WO2002004681A2 Method of detection by enhancement of silver staining |
| 01/17/2002 | WO2002004680A2 Real-time sequence determination |
| 01/17/2002 | WO2002004678A2 Methods and compositions for diagnosing and treating preeclampsia and gestational trophoblast disorders |
| 01/17/2002 | WO2002004677A2 Methods for diagnosis and treatment of psychiatric disorders |
| 01/17/2002 | WO2002004674A2 Transposon mediated multiplex sequencing |
| 01/17/2002 | WO2002004672A2 Diagnostic method for the identification of foetal dna in a maternal sample |
| 01/17/2002 | WO2002004671A2 Improved binding interactions in dipstick assays |
| 01/17/2002 | WO2002004670A2 Improved capture and detection of target nucleic acid in dipstick assays |
| 01/17/2002 | WO2002004669A2 Improved capture and detection format versatility for dipstick assays |
| 01/17/2002 | WO2002004668A2 Improved capture and detection of target nucleic acid in dipstick assays |
| 01/17/2002 | WO2002004667A2 Improved detection signal and capture in dipstick assays |
| 01/17/2002 | WO2002004665A2 Method with a wide range of applications, for identifying modulators of g-protein-coupled receptors |
| 01/17/2002 | WO2002004661A2 Methods for classifying nucleic acids and polypeptides |
| 01/17/2002 | WO2002004659A2 Relative rates of cytochrome p450 metabolism |
| 01/17/2002 | WO2002004658A1 Compositions to measure protein concentration |
| 01/17/2002 | WO2002004657A2 Screening method |
| 01/17/2002 | WO2002004656A2 Bio-probes and use thereof |
| 01/17/2002 | WO2002004655A2 Cation mediated triplex hybridization assay |
| 01/17/2002 | WO2002004654A2 Method for determining an<i> in vitro</i> cell model imitating the expression profile of a gene of interest in an <i>in vivo</i> cell |
| 01/17/2002 | WO2002004641A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/17/2002 | WO2002004640A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/17/2002 | WO2002004636A1 NOVEL α-CATENIN EXPRESSED IN HEART AND TESTIS |
| 01/17/2002 | WO2002004612A2 Drug metabolizing enzymes |
| 01/17/2002 | WO2002004611A2 Aminoacyl trna synthetases |
| 01/17/2002 | WO2002004607A1 Human myeloma cell line |
| 01/17/2002 | WO2002004602A1 Transformed yeast presenting protein a on the cell surface layer |
| 01/17/2002 | WO2002004596A2 Diagnosing and treating cancer cells using mutant viruses |
| 01/17/2002 | WO2002004562A2 Fluorescein-based metal sensors, and methods of making and using the same |
| 01/17/2002 | WO2002004555A1 Superparamagnetic pearl polymers |
| 01/17/2002 | WO2002004527A2 Encoding methods using up-converting phosphors for high-throughput screening of catalysts |
| 01/17/2002 | WO2002004523A2 Artificial antibody polypeptides |
| 01/17/2002 | WO2002004520A2 Transporters and ion channels |
| 01/17/2002 | WO2002004513A2 Down syndrome critical region 1-like 1 proteins |
| 01/17/2002 | WO2002004511A2 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS |
| 01/17/2002 | WO2002004509A2 Gene expression, genome alteration and reporter expression in myofibroblasts and myofibroblast-like cells |
| 01/17/2002 | WO2002004492A2 Herpes zinc finger motifs |
| 01/17/2002 | WO2002004491A2 Methods and compositions relating to muscle selective calcineurin interacting protein (mcip) |
| 01/17/2002 | WO2002004490A2 Lipid metabolism molecules |
| 01/17/2002 | WO2002004489A2 Polymorphic kinase anchor proteins and nucleic acids encoding the same |
| 01/17/2002 | WO2002004484A2 Hcv mosaic antigen composition |
| 01/17/2002 | WO2002004482A1 Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases |
| 01/17/2002 | WO2002004477A2 Combination of microporous membrane and solid support for microdiagnostics |
| 01/17/2002 | WO2002004465A1 Methods and kits for the detection of arginine compounds |
| 01/17/2002 | WO2002004433A2 Melanin concentrating hormone receptor ligands |
| 01/17/2002 | WO2002004431A1 Silent mark for oil product and detection method thereto |
| 01/17/2002 | WO2002004202A1 Substrates for powder deposition containing conductive domains |
| 01/17/2002 | WO2002004185A1 Process and installation for separating plastics, according to type, from recycled plastic mixtures |
| 01/17/2002 | WO2002004113A2 Methods of patterning protein and cell adhesivity |
| 01/17/2002 | WO2002004102A2 Membrane and method for making same with consistent wicking properties for lateral flow assays |
| 01/17/2002 | WO2002004029A1 Olfactory neuron cultures and method of making and using the same |
| 01/17/2002 | WO2002004028A1 Methods of modulating wound healing and angiogenesis |
| 01/17/2002 | WO2002003921A2 Bax fragment induced tumor cell death |
| 01/17/2002 | WO2002003919A2 Structural targets in hepatitis c virus ires element |
| 01/17/2002 | WO2002003911A2 Prevention and treatment of alzheimer's disease |
| 01/17/2002 | WO2001072962A3 Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 01/17/2002 | WO2001067094A3 Device and method for bringing a compound into contact with an environment |
| 01/17/2002 | WO2001051922A3 Identification of peripheral benzodiazepine receptor binding agents |
| 01/17/2002 | WO2001047950A3 Basolateral sorting signal based on scf peptide and inhibitors thereof |
| 01/17/2002 | WO2001044448A3 Human oxidoreductase proteins |
| 01/17/2002 | WO2001044291A3 Polynucleotid encoding the rg1 polypeptide |
| 01/17/2002 | WO2001042299A3 Hepatitis virus sentinel virus i (svi) |
| 01/17/2002 | WO2001042211A3 Detection of transmembrane potentials by optical methods |
| 01/17/2002 | WO2001041740A3 Reconstitution of purified membrane proteins into preformed liposomes |
| 01/17/2002 | WO2001040758A3 A method for high throughput thermodynamic screening of ligands |
| 01/17/2002 | WO2001040312A3 Naive screening method |
| 01/17/2002 | WO2001040148A3 Systems and methods to facilitate multiple order combinatorial chemical processes |
| 01/17/2002 | WO2001038878A3 Pin1 as a marker for abnormal cell growth |
| 01/17/2002 | WO2001036965A3 Electric substance detectors comprising cellular material |
| 01/17/2002 | WO2001036682A3 Long oligonucleotide arrays |
| 01/17/2002 | WO2001036461A3 Compositions and methods for regulating tumor-associated antigen expression |
| 01/17/2002 | WO2001035101A3 Mutual suppression between sex hormone and other nuclear receptors |
| 01/17/2002 | WO2001034846A3 Direct mapping of dna chips to detector arrays |
| 01/17/2002 | WO2001034833A3 Regulating endogenous inhibitor at atp synthase |
| 01/17/2002 | WO2001034769A3 24 human secreted proteins |
| 01/17/2002 | WO2001032876A3 Compositions and methods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions |
| 01/17/2002 | WO2001032696A3 Traf family proteins |
| 01/17/2002 | WO2001031344A3 Glycerol as a predictor of glucose tolerance |
| 01/17/2002 | WO2001031011A3 Gene mining system and method |
| 01/17/2002 | WO2001030497A3 The meso sniffer: a device and method for active gas sampling using alternating flow |
| 01/17/2002 | WO2001029072A3 P15paf cell cycle proteins associated with pcna, compositions and methods of use |
| 01/17/2002 | WO2001027623A3 Isoagglutinin-depleted blood compositions and methods of making same |
| 01/17/2002 | WO2001027317A3 Method for distinguishing 5-position methylation changes |
| 01/17/2002 | WO2001027290A3 Aortic carboxypeptidase-like protein and nucleic acids encoding same |
| 01/17/2002 | WO2001020019A3 Implantable glucose sensor |
| 01/17/2002 | WO2001016858A3 System and method for genomic and proteomic human disease assessment via expression profile comparison |